1-218434154-G-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_003238.6(TGFB2):c.583G>T(p.Glu195*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000657 in 152,234 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_003238.6 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TGFB2 | NM_003238.6 | c.583G>T | p.Glu195* | stop_gained | Exon 3 of 7 | ENST00000366930.9 | NP_003229.1 | |
TGFB2 | NM_001135599.4 | c.667G>T | p.Glu223* | stop_gained | Exon 4 of 8 | NP_001129071.1 | ||
TGFB2 | NR_138148.2 | n.1949G>T | non_coding_transcript_exon_variant | Exon 3 of 7 | ||||
TGFB2 | NR_138149.2 | n.2033G>T | non_coding_transcript_exon_variant | Exon 4 of 8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGFB2 | ENST00000366930.9 | c.583G>T | p.Glu195* | stop_gained | Exon 3 of 7 | 1 | NM_003238.6 | ENSP00000355897.4 | ||
TGFB2 | ENST00000366929.4 | c.667G>T | p.Glu223* | stop_gained | Exon 4 of 8 | 1 | ENSP00000355896.4 | |||
TGFB2 | ENST00000479322.1 | n.29G>T | non_coding_transcript_exon_variant | Exon 1 of 5 | 3 | |||||
TGFB2 | ENST00000488793.1 | n.247G>T | non_coding_transcript_exon_variant | Exon 3 of 3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152234Hom.: 0 Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152234Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74380
ClinVar
Submissions by phenotype
Loeys-Dietz syndrome 4 Pathogenic:1
This sequence change creates a premature translational stop signal (p.Glu195*) in the TGFB2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TGFB2 are known to be pathogenic (PMID: 22772368, 22772371, 30739908). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with TGFB2-related conditions. ClinVar contains an entry for this variant (Variation ID: 213841). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
p.Glu195Ter (GAA>TAA): c.583 G>T in exon 3 of the TGFB2 gene (NM_003238.3). Mutations in TGFB2 are found in approximately 1% of individuals with Loeys-Dietz syndrome (LDS; Loeys BL and Dietz HC, 2013). Patients with a mutation in TGFB2 may present with a milder phenotype, although features of classic LDS may occur (Boileau et al., 2012). Features common in carriers of mutations in TGFB2 include club feet and mitral valve disease (Loeys BL and Dietz HC, 2013).The E195X mutation in the TGFB2 gene has not been reported as a disease-causing mutation or as a benign polymorphism to our knowledge. E195X is predicted to cause loss of normal protein function either by protein truncation or nonsense-mediated mRNA decay. Other nonsense mutations in the TGFB2 gene have been reported in association with a TAAD-related disorder. In summary, E195X in the TGFB2 gene is interpreted as a disease-causing mutation. This variant was found in TAAD. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at